Device / Technology News

RSS

AiCure closes $12.25 million in Series A fundraising round

AiCure, an artificial intelligence company connecting the world's patients to better treatments and improved health, has closed a Series A fundraising round with $12.25 million. The consortium is led by New Leaf Venture Partners, with additional participation from Pritzker Group Venture Capital, Tribeca Venture Partners, and Biomatics Capital, established by Boris Nikolic, former Chief Advisor for Science and Technology to Bill Gates.

11 Jan 2016

Bio2 Technologies receives 510(k) clearance from FDA for Fusion Implant system

Bio2 Technologies, Inc. announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Fusion Implant system for interphalangeal fusion, fracture repair and osteotomies of the toes, fingers and other small bones in the presence of appropriate immobilization.

11 Jan 2016

BlueWind completes patient enrolment for Overactive Bladder study to support CE Mark submission

BlueWind Medical, developer of a wireless neuro-stimulation device to treat multiple clinical indications, such as back pain, peripheral neuropathic pain, incontinence (OAB), epilepsy, and more, announced today the completion of patient enrolment for an Overactive Bladder (OAB) study which is currently being conducted to support CE Mark submission.

11 Jan 2016

NIST chemist develops portable kit for recovering traces of chemical evidence

A chemist at the National Institute of Standards and Technology has developed a portable version of his method for recovering trace chemicals such as environmental pollutants and forensic evidence including secret graves and arson fire debris.

11 Jan 2016

New Qlucore Omics Explorer software aids researchers to perform deeper data analysis, biomarker discovery

Qlucore, a world leader in the development of bioinformatics software, has today unveiled Qlucore Omics Explorer 3.2, the latest version of its advanced data analysis software.

11 Jan 2016

New blood test could predict women at higher risk of preeclampsia

The causes of preeclampsia, a multi-system disorder that affects women in pregnancy, have not been fully elucidated. The condition, which is typically associated with high blood pressure and an increased amount of protein in the urine, affects 2 to 5 percent of pregnant women, and is one of the main reasons for complications during the second half of pregnancy. Preeclampsia is frequently diagnosed too late and, in the most severe cases, can be fatal for both mother and child.

11 Jan 2016

Braces halt further progression of spinal curve, surgery in adolescent scoliosis patients

Bracing often is recommended for adolescents diagnosed with idiopathic adolescent scoliosis, and a spinal curve between 25 and 45 degrees. When worn consistently and as directed, braces have been found to effectively halt or slow further progression of a spinal curve, often preventing surgery.

11 Jan 2016

New gene editing technique could hinder retinal degeneration in rats with inherited blindness

A new technique that has the potential to treat inherited diseases by removing genetic defects has been shown for the first time to hinder retinal degeneration in rats with a type of inherited blindness, according to a Cedars-Sinai study.

11 Jan 2016

Wyss Institute scientists develop better assay for testing hemostasis

Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University have devised a better assay for testing blood's clotting tendency, also known as hemostasis, which could one day prove lifesaving in a variety of clinical situations in which a patient's health is jeopardized by abnormal blood coagulation and platelet function.

11 Jan 2016

BookWise Solutions installs unique software package at Southmead Hospital's renal department in Bristol

UK healthcare scheduling expert BookWise Solutions Limited has expanded its services in Southmead Hospital in Bristol by installing a brand new, unique software package in Dialysis Services at the hospital’s renal department.

8 Jan 2016

New project aims to develop CAR-T cell immuno-oncology cellular therapy for solid tumours

The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, the University of Birmingham and Cancer Research Technology, the commercialisation arm of Cancer Research UK, announces today the launch of a collaboration to develop a new immuno-oncology cellular therapy based on gene modifying T cells to target solid tumours.

8 Jan 2016

Anthony Nolan introduces new tissue typing method that could revolutionise stem cell transplantation

Anthony Nolan has today launched a new tissue typing method that could significantly improve stem cell transplant outcomes.

8 Jan 2016

Roche’s Elecsys blood test could help predict pre-eclampsia in pregnant women

A new study published in the New England Journal of Medicine today shows that Roche’s Pre-eclampsia Elecsys® blood test can predict which pregnant women will, and will not, develop pre-eclampsia, one of the leading causes of death and complications for mothers and their unborn babies.

8 Jan 2016

AngioDefender holds much promise for personalized cardiac care

For a non-descript box it wields a mighty name and even more impressive possibilities for people with heart disease. Called the AngioDefender, the machine - no bigger than a shoebox - holds much promise in the ability to personalize cardiac care, say researchers at Lawson Health Research Institute, the research arm of St. Joseph's Health Care London.

8 Jan 2016

Oxygen sensor PHD1 identified as potential target for treatment of ischemic stroke

Scientists at VIB and KU Leuven have identified the oxygen sensor PHD1 as a potential target for the treatment of brain infarction (ischemic stroke). Despite (minor) improvements in stroke treatment, stroke remains the fourth leading cause of death and the most common reason of severe disability.

8 Jan 2016

ImpediMed introduces L-Dex system for clinical assessment of lymphedema in U.S.

ImpediMed Limited, a global provider of medical technology to measure, monitor and manage fluid status in patients, has announced the U.S. commercial launch of its L-Dex system to aid in the clinical assessment of lymphedema.

7 Jan 2016

ACell launches two new wound management devices

ACell, Inc. today announced the introduction of two new wound management devices: Cytal Wound Matrix 3-Layer and Cytal Wound Matrix 6-Layer. These devices are intended for the management of partial- and full-thickness wounds including pressure ulcers, venous ulcers, diabetic ulcers, tunneled wounds, traumatic wounds, and surgical wounds.

7 Jan 2016

Integra Omnigraft Dermal Regeneration Matrix approved to treat certain diabetic foot ulcers

The U.S. Food and Drug Administration today approved a new indication for the Integra Omnigraft Dermal Regeneration Matrix (Omnigraft) to treat certain diabetic foot ulcers. The matrix device, which is made of silicone, cow collagen, and shark cartilage, is placed over the ulcer and provides an environment for new skin and tissue to regenerate and heal the wound.

7 Jan 2016

ß-Hydroxybutyrate LiquiColor® reagent system to detect ketosis

Stanbio Laboratory, an EKF company, has developed the ß-Hydroxybutyrate LiquiColor® Reagent System to improve the detection of clinically significant ketosis.

From EKF Diagnostics 7 Jan 2016

New handheld blood test to detect and evaluate concussions to be developed by Philips and Banyan Biomarkers

Royal Philips and Banyan Biomarkers, Inc. today announced that they have entered into a multi-year joint development agreement to develop and commercialize a new handheld blood test to detect and evaluate mild traumatic brain injury (TBI) - also known as concussion - at the point of care.

From Philips Healthcare 7 Jan 2016

Device / Technology News

AiCure closes $12.25 million in Series A fundraising round

Bio2 Technologies receives 510(k) clearance from FDA for Fusion Implant system

BlueWind completes patient enrolment for Overactive Bladder study to support CE Mark submission

NIST chemist develops portable kit for recovering traces of chemical evidence

New Qlucore Omics Explorer software aids researchers to perform deeper data analysis, biomarker discovery

New blood test could predict women at higher risk of preeclampsia

Braces halt further progression of spinal curve, surgery in adolescent scoliosis patients

New gene editing technique could hinder retinal degeneration in rats with inherited blindness

Wyss Institute scientists develop better assay for testing hemostasis

BookWise Solutions installs unique software package at Southmead Hospital's renal department in Bristol

New project aims to develop CAR-T cell immuno-oncology cellular therapy for solid tumours

Anthony Nolan introduces new tissue typing method that could revolutionise stem cell transplantation

Roche’s Elecsys blood test could help predict pre-eclampsia in pregnant women

AngioDefender holds much promise for personalized cardiac care

Oxygen sensor PHD1 identified as potential target for treatment of ischemic stroke

ImpediMed introduces L-Dex system for clinical assessment of lymphedema in U.S.

ACell launches two new wound management devices

Integra Omnigraft Dermal Regeneration Matrix approved to treat certain diabetic foot ulcers

ß-Hydroxybutyrate LiquiColor® reagent system to detect ketosis

New handheld blood test to detect and evaluate concussions to be developed by Philips and Banyan Biomarkers

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Latest News